Skip to main content
Signal8

SCHACHLE JOSEPH K

SEC insider (Form 3/4/5 filer). CIK 0001145914. Chief Operating Officer at Opus Genetics, Inc. (IRD). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in DURHAM, NC.

Companies SCHACHLE JOSEPH K has filed insider reports for

  • Opus Genetics, Inc. (IRD): Officer, Chief Operating Officer
SCHACHLE JOSEPH K profile photo

SCHACHLE JOSEPH K

CIK: 0001145914

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Opus Genetics, Inc. logo
IRD

Opus Genetics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Oct 23, 2026
    Sale
    Direct
    4.8K shares at avg. $3.56$17K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jul 23, 2026
    Sale
    Direct
    4.6K shares at avg. $2.94$14K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Apr 23, 2026
    Sale
    Direct
    4.7K shares at avg. $5.22$25K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Mar 16, 2026
    Sale
    Direct
    3.7K shares at avg. $5.25$20K
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Jan 22, 2026
    Award
    Direct
    250K shares-
  • Opus Genetics, Inc. logo
    IRD

    Opus Genetics, Inc.

    Mar 13, 2025
    Award
    Direct
    52.5K shares-

1-6 of 6